Drugs / Fibersol-2
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03565393 | Mar 2018 → Mar 2019 | diarrheal disease | International Centre for Diarrhoeal Disease Research, Bangladesh | Completed | Missed primary |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fibersol-2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03565393 ↗ |
| Known as | resistant maltodextrin | “Resistant maltodextrin (Fibersol-2) is a low viscosity, water-soluble, indigestible dextrin produced by the treatment of corn starch with acid, enzymes, and heat.” NCT03565393 ↗ |
| Modality | Other / unclassified | “Resistant maltodextrin (Fibersol-2) is a low viscosity, water-soluble, indigestible dextrin produced by the treatment of corn starch with acid, enzymes, and heat.” NCT03565393 ↗ |
| Route | Oral | “was given orally to ninety-two children with watery diarrhea on enrollment twice daily for a period of 7 days” PMID 36706123 ↗ Jan 2023 |